Recombinant Pan troglodytes Epithelial membrane protein 2 (EMP2)

What is the structure of EMP2 and how does it compare between humans and chimpanzees?

EMP2 is a tetraspan protein consisting of 167 amino acids in humans, with four transmembrane domains that mediate its various cellular functions . The protein contains several functional regions, including domains responsible for protein-protein interactions and membrane integration.

When comparing human and chimpanzee (Pan troglodytes) EMP2, researchers should note that while the proteins share high sequence homology due to the close evolutionary relationship between the species , the specific amino acid differences may lead to subtle functional variations in protein-protein interactions or membrane integration efficiency. Methodologically, sequence analysis using alignment tools like CLUSTAL Omega or MUSCLE is recommended for identifying conserved and variable regions between the orthologs.

What are the primary biological functions of EMP2?

EMP2 functions as a master regulator of cell membrane protein trafficking and composition, affecting multiple cellular processes:

• Membrane organization: EMP2 facilitates surface trafficking and formation of lipid rafts bearing GPI-anchored proteins

• Protein surface expression regulation: Controls the plasma membrane expression of integrin heterodimers (ITGA6-ITGB1, ITGA5-ITGB3, ITGA5-ITGB1)

• Cell adhesion modulation: Regulates focal adhesion density, F-actin conformation, and cell adhesion capacity

• Cell migration and invasion: Promotes cell migration through PTK2 and SRC activation

• Angiogenesis: Regulates blood vessel endothelial cell migration and angiogenesis by regulating VEGF protein expression

• Immune function: Regulates surface expression of MHC1 and ICAM1, affecting T-cell mediated cytotoxicity

Research methodologies investigating these functions should employ appropriate cell-based assays, such as adhesion assays, wound healing assays for migration, tube formation assays for angiogenesis, and co-immunoprecipitation for protein interaction studies.

How does EMP2 expression vary across different tissue types?

EMP2 expression exhibits significant tissue specificity with important pathological implications:

When designing experiments, researchers should carefully select appropriate control tissues and consider the specific pathological context to properly interpret EMP2 expression data.

What expression systems are most effective for producing recombinant Pan troglodytes EMP2?

Based on successful production of human EMP2, researchers working with Pan troglodytes EMP2 should consider:

• Wheat germ cell-free expression system: Successfully used for human EMP2 expression , this system is advantageous for membrane proteins as it avoids toxicity issues often encountered in bacterial systems

• Mammalian expression systems: HEK293 or CHO cells may provide proper post-translational modifications

• Baculovirus-insect cell system: Suitable for membrane proteins requiring complex folding

When establishing an expression protocol, researchers should optimize codon usage for the selected expression system, consider adding purification tags (His, FLAG, or GST) at either N- or C-terminus (avoiding disruption of transmembrane domains), and implement rigorous quality control measures using SDS-PAGE, Western blotting, and mass spectrometry.

What purification challenges are specific to recombinant EMP2 and how can they be addressed?

As a tetraspan membrane protein, EMP2 presents several purification challenges:

• Solubility issues: EMP2's hydrophobic transmembrane domains make it prone to aggregation. Methodology recommendation: Use mild detergents such as n-dodecyl-β-D-maltoside (DDM) or lauryl maltose neopentyl glycol (LMNG) during extraction and purification.

• Maintaining native conformation: Critical for functional studies. Methodology recommendation: Employ detergent screening to identify conditions that preserve protein structure; consider nanodiscs or amphipols for detergent-free stabilization.

• Heterogeneity: Multiple oligomeric states may occur. Methodology recommendation: Implement size exclusion chromatography as a final purification step to isolate homogeneous populations.

• Functional validation: Essential to confirm biological activity. Methodology recommendation: Develop binding assays with known interaction partners (e.g., integrins) or cell-based functional assays appropriate to the research question.

How can researchers effectively design experiments to study EMP2's role in cell migration and invasion?

Given EMP2's established role in promoting cell migration and invasion in human GBM , researchers studying Pan troglodytes EMP2 should consider these methodological approaches:

• Gain and loss of function models:

  • Overexpression systems using lentiviral or retroviral vectors

  • siRNA or CRISPR-Cas9 for knockdown/knockout studies

  • Comparison between human and chimpanzee EMP2 to identify species-specific effects

• Migration assays:

  • Transwell migration assays with appropriate ECM coating

  • Wound healing assays with time-lapse microscopy

  • 3D spheroid invasion assays in matrix that better recapitulate in vivo conditions

• Molecular pathway analysis:

  • Phosphorylation status of FAK and Src kinases, which are activated downstream of EMP2

  • Integrin expression profiling, particularly αvβ3 integrin which is upregulated by EMP2

  • Live-cell imaging to track focal adhesion dynamics using fluorescently tagged proteins

• In vivo models:

  • Intracranial xenograft models similar to those used for human EMP2 studies

  • Comparison of invasive properties between cells expressing human versus Pan troglodytes EMP2

How should researchers approach studying EMP2's interactions with integrins and other membrane proteins?

EMP2 regulates the plasma membrane expression of several integrin heterodimers (ITGA6-ITGB1, ITGA5-ITGB3, ITGA5-ITGB1) , which influences cell-matrix adhesion. Recommended methodological approaches include:

• Co-immunoprecipitation assays:

  • Use anti-EMP2 antibodies to pull down protein complexes

  • Western blot analysis to detect associated integrins and other binding partners

  • Compare interaction profiles between human and Pan troglodytes EMP2

• Proximity ligation assays (PLA):

  • Detect protein-protein interactions in situ with subcellular resolution

  • Particularly valuable for membrane protein interactions that may be disrupted during cell lysis

• FRET/BRET analysis:

  • Measure direct protein interactions in living cells

  • Requires fluorescent/bioluminescent protein fusions that maintain normal protein function

• Surface plasmon resonance (SPR):

  • Determine binding kinetics and affinities between purified proteins

  • Requires purified recombinant proteins in functional conformations

• Proteomics approaches:

  • Stable isotope labeling by amino acids in cell culture (SILAC) to quantify changes in the membrane proteome upon EMP2 manipulation

  • Cross-linking mass spectrometry to identify direct interaction partners

What methodologies are recommended for studying the role of EMP2 in angiogenesis?

EMP2 regulates blood vessel endothelial cell migration and angiogenesis by modulating VEGF protein expression through PTK2 activation . Studies with recombinant Pan troglodytes EMP2 should consider:

• In vitro angiogenesis assays:

  • Endothelial tube formation assays on Matrigel

  • Endothelial cell migration and proliferation assays

  • 3D sprouting assays from endothelial spheroids

• Molecular signaling analysis:

  • VEGF expression and secretion measurements

  • PTK2 (FAK) phosphorylation status

  • HIF-1α expression, which increases in EMP2-deficient conditions

• Ex vivo models:

  • Aortic ring assays to assess vessel sprouting

  • Comparison between tissues exposed to human versus Pan troglodytes EMP2

• In vivo models:

  • Matrigel plug assays with conditioned media from cells expressing recombinant EMP2

  • Developing transgenic models with regulated expression of Pan troglodytes EMP2

How can researchers reconcile contradictory findings regarding EMP2's role in different tissue contexts?

EMP2 exhibits seemingly contradictory roles across different tissues and disease states. For instance:

When confronting such contradictions, researchers should:

• Consider tissue-specific interaction partners: Perform tissue-specific interactome studies to identify differential binding partners that may explain context-dependent functions.

• Examine microenvironmental influences: Design experiments that account for tissue-specific extracellular matrix components, oxygen tensions, and cytokine milieus.

• Investigate isoform-specific effects: Determine if alternative splicing or post-translational modifications differ between tissues, potentially explaining functional differences.

• Employ systems biology approaches: Construct tissue-specific protein-protein interaction networks to predict how EMP2 functions within different cellular contexts.

• Consider evolutionary perspectives: Compare functional differences between human and Pan troglodytes EMP2 to identify conserved versus divergent roles.

What approaches are most effective for studying EMP2's role in disease processes like cancer or placental insufficiency?

EMP2 has been implicated in both cancer progression and placental development, making it a complex target for disease-focused research . Effective methodological approaches include:

• Integrated multi-omics analysis:

  • Combine transcriptomics, proteomics, and phosphoproteomics data

  • Identify disease-specific pathway alterations associated with EMP2 expression changes

• Patient-derived models:

  • Use patient-derived xenografts or organoids to maintain disease heterogeneity

  • Compare EMP2 function in normal versus diseased tissues from the same patient

• Conditional knockout models:

  • Develop tissue-specific and temporally controlled EMP2 knockout models

  • Particularly important for studying developmental roles in placentation

• Therapeutic targeting approaches:

  • Develop and test anti-EMP2 antibodies, similar to those used in GBM models

  • Compare efficacy between antibodies targeting human versus Pan troglodytes EMP2

  • Evaluate both on-target and off-target effects across multiple tissues

• Biomarker validation studies:

  • Correlate EMP2 expression with clinical outcomes across large patient cohorts

  • Develop standardized protocols for EMP2 detection in clinical samples

How should researchers interpret species differences when using Pan troglodytes EMP2 as a model for human EMP2 function?

When comparing Pan troglodytes and human EMP2, researchers should systematically address:

• Sequence divergence analysis:

  • Identify amino acid differences, particularly in functional domains

  • Predict structural impacts using molecular modeling

• Functional conservation assessment:

  • Perform side-by-side functional assays with recombinant proteins from both species

  • Quantify differences in binding affinities to conserved partners

• Species-specific interaction networks:

  • Map and compare protein-protein interaction networks

  • Identify interaction partners that differ between species

• Evolutionary context interpretation:

  • Consider the broader evolutionary context of observed differences

  • Determine if differences reflect adaptive changes or neutral evolution

• Translational relevance evaluation:

  • Assess whether species differences impact the translational relevance of findings

  • Consider creating humanized models when appropriate

What quality control measures are essential when working with recombinant Pan troglodytes EMP2?

Rigorous quality control is essential for reproducible research with recombinant proteins:

• Protein identity verification:

  • Mass spectrometry analysis to confirm amino acid sequence

  • Peptide mapping to verify complete protein coverage

• Purity assessment:

  • SDS-PAGE with Coomassie or silver staining (aim for >90% purity)

  • Western blotting with specific anti-EMP2 antibodies

• Structural integrity evaluation:

  • Circular dichroism spectroscopy to assess secondary structure

  • Size exclusion chromatography to detect aggregation

• Functional validation:

  • Binding assays with known interaction partners

  • Cell-based functional assays appropriate to research context

• Lot-to-lot consistency:

  • Implement standardized quality metrics for batch release

  • Maintain detailed records of production parameters

How can researchers troubleshoot common experimental issues with recombinant EMP2?